These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8818040)
1. Comparison of reversed phase and reversed phase ion pair high performance liquid chromatography for analysis of TcO and TcN complexes of L,L-ethylene dicysteine di-ethylester and its acid analogues. Mang'era KO; Bellande E; Pasqualini R; Verbruggen A J Pharm Biomed Anal; 1996 Jun; 14(8-10):1241-4. PubMed ID: 8818040 [TBL] [Abstract][Full Text] [Related]
2. Influence of a 99mTcN core on the biological and physicochemical behavior of 99mTc complexes of L,L-EC and L,L-ECD. Mang'era KO; Vanbilloen HP; Bellande E; Pasqualini R; Verbruggen AM Nucl Med Biol; 1996 Nov; 23(8):987-93. PubMed ID: 9004286 [TBL] [Abstract][Full Text] [Related]
3. Importance of the two ester functions for the brain retention of 99mTc-labelled ethylene dicysteine diethyl ester (99mTc-ECD). Vanbilloen HP; Cleynhens BJ; Verbruggen AM Nucl Med Biol; 1998 Aug; 25(6):569-75. PubMed ID: 9751425 [TBL] [Abstract][Full Text] [Related]
5. Identity confirmation of 99mTc-MAG3, 99mTc-sestamibi and 99mTc-ECD using radio-LC-MS. Verduyckt T; Kieffer D; Huyghe D; Cleynhens B; Verbeke K; Verbruggen A; Bormans G J Pharm Biomed Anal; 2003 Aug; 32(4-5):669-78. PubMed ID: 12899957 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers. Walovitch RC; Franceschi M; Picard M; Cheesman EH; Hall KM; Makuch J; Watson MW; Zimmerman RE; Watson AD; Ganey MV Neuropharmacology; 1991 Mar; 30(3):283-92. PubMed ID: 1906585 [TBL] [Abstract][Full Text] [Related]
7. Preparation and biological behaviour of 99mTc-carbonyl and 99mTc-nitrido complexes of cysteine and some cysteine esters. Bonnyman J Nucl Med Biol; 1995 Oct; 22(7):943-8. PubMed ID: 8547893 [TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoretic analysis of ethylene dicysteine, a precursor of the radiopharmaceutical 99mTc ethylene dicysteine. Van Schepdael A; Verbeke K; Van Nerom C; Hoogmartens J; Verbruggen A J Chromatogr B Biomed Sci Appl; 1997 Sep; 697(1-2):251-4. PubMed ID: 9342676 [TBL] [Abstract][Full Text] [Related]
9. Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole. Song HC; Bom HS; Cho KH; Kim BC; Seo JJ; Kim CG; Yang DJ; Kim EE Stroke; 2003 Apr; 34(4):982-6. PubMed ID: 12649518 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue. Inoue Y; Momose T; Ohtake T; Nishikawa J; Sasaki Y; Waritani T; Inoue M J Nucl Med; 1997 Nov; 38(11):1731-7. PubMed ID: 9374342 [TBL] [Abstract][Full Text] [Related]
12. Substitution reactions of 99mTcNCl-4--A route to a new class of 99mTc-radiopharmaceuticals. Baldas J; Bonnyman J Int J Appl Radiat Isot; 1985 Feb; 36(2):133-9. PubMed ID: 2984125 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups. Liu S; He Z; Hsieh WY; Kim YS Nucl Med Biol; 2006 Apr; 33(3):419-32. PubMed ID: 16631092 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH. Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976 [TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO]. Makino K; Masuda Y; Gotoh S Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624 [TBL] [Abstract][Full Text] [Related]
17. Quantitative HPLC determination of [99mTc]-pertechnetate in radiopharmaceuticals and biological samples--I. Technique development. Zhou TZ; Hirth WW; Heineman WR; Deutsch E Int J Rad Appl Instrum B; 1988; 15(5):493-8. PubMed ID: 2855519 [TBL] [Abstract][Full Text] [Related]
18. Preparation of 99mTc-ethylene dicysteine (99mTc-EC) by transchelation using 99mTc-glucoheptonate (99mTc-GHA) and its evaluation for renal function studies. Vanaja R; Solav SV; Joshi SH; Kumar P; Ramamoorthy N Nucl Med Commun; 2000 Oct; 21(10):977-82. PubMed ID: 11130341 [TBL] [Abstract][Full Text] [Related]
19. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168 [TBL] [Abstract][Full Text] [Related]
20. [Usefulness of 99mTc-ECD SPECT in diseases of the central nerve system: special reference to a comparison with 123I-IMP and 99mTc-HM-PAO SPECT]. Ono S; Yanagimoto S; Mimura H; Otsuka N; Nagai K; Morita K; Tomomitsu T; Muranaka A; Watanabe A; Ishii R Kaku Igaku; 1992 Dec; 29(12):1429-40. PubMed ID: 1491488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]